

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | polyketide metabolic process (GO:0030638) | 8.89933934 |
| 2 | doxorubicin metabolic process (GO:0044598) | 8.89933934 |
| 3 | daunorubicin metabolic process (GO:0044597) | 8.89933934 |
| 4 | fat-soluble vitamin catabolic process (GO:0042363) | 8.73532813 |
| 5 | vitamin catabolic process (GO:0009111) | 8.73532813 |
| 6 | vitamin D metabolic process (GO:0042359) | 8.41354448 |
| 7 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.88337190 |
| 8 | interferon-gamma secretion (GO:0072643) | 6.97089715 |
| 9 | cellular response to vitamin D (GO:0071305) | 6.34478309 |
| 10 | regulation of cardioblast differentiation (GO:0051890) | 6.00313086 |
| 11 | urate metabolic process (GO:0046415) | 5.75062982 |
| 12 | regulation of guanylate cyclase activity (GO:0031282) | 5.74941394 |
| 13 | sulfate transmembrane transport (GO:1902358) | 5.53256607 |
| 14 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.24928920 |
| 15 | toxin transport (GO:1901998) | 5.20759549 |
| 16 | folic acid transport (GO:0015884) | 5.12070970 |
| 17 | iron ion import (GO:0097286) | 4.98290619 |
| 18 | folic acid metabolic process (GO:0046655) | 4.94916321 |
| 19 | modified amino acid transport (GO:0072337) | 4.89345884 |
| 20 | cellular response to vitamin (GO:0071295) | 4.82597130 |
| 21 | drug transmembrane transport (GO:0006855) | 4.82020693 |
| 22 | sulfate transport (GO:0008272) | 4.77670344 |
| 23 | cysteine metabolic process (GO:0006534) | 4.70326489 |
| 24 | regulation of transforming growth factor beta2 production (GO:0032909) | 4.60257603 |
| 25 | phosphate ion transmembrane transport (GO:0035435) | 4.43728658 |
| 26 | drug transport (GO:0015893) | 4.41871863 |
| 27 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.41547448 |
| 28 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.34558540 |
| 29 | excretion (GO:0007588) | 4.32958958 |
| 30 | cytidine deamination (GO:0009972) | 4.29678737 |
| 31 | cytidine metabolic process (GO:0046087) | 4.29678737 |
| 32 | cytidine catabolic process (GO:0006216) | 4.29678737 |
| 33 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 4.27265793 |
| 34 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.21732679 |
| 35 | intestinal cholesterol absorption (GO:0030299) | 4.18892289 |
| 36 | glycoside metabolic process (GO:0016137) | 4.15895259 |
| 37 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 4.12370178 |
| 38 | plasma lipoprotein particle assembly (GO:0034377) | 4.10822686 |
| 39 | positive regulation of hair cycle (GO:0042635) | 4.06159904 |
| 40 | positive regulation of hair follicle development (GO:0051798) | 4.06159904 |
| 41 | phosphate ion transport (GO:0006817) | 3.95254105 |
| 42 | negative regulation of metanephros development (GO:0072217) | 3.92507263 |
| 43 | response to dietary excess (GO:0002021) | 3.90102236 |
| 44 | quinone metabolic process (GO:1901661) | 3.88984031 |
| 45 | vitamin transport (GO:0051180) | 3.88210715 |
| 46 | amino sugar catabolic process (GO:0046348) | 3.79260616 |
| 47 | sulfur compound transport (GO:0072348) | 3.76324352 |
| 48 | response to vitamin D (GO:0033280) | 3.76064215 |
| 49 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.70724831 |
| 50 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.65834605 |
| 51 | purine nucleobase biosynthetic process (GO:0009113) | 3.64496095 |
| 52 | regulation of histone H3-K27 methylation (GO:0061085) | 3.64420435 |
| 53 | fat-soluble vitamin metabolic process (GO:0006775) | 3.58299521 |
| 54 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.58075236 |
| 55 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.53794093 |
| 56 | protein carboxylation (GO:0018214) | 3.53794093 |
| 57 | cellular glucuronidation (GO:0052695) | 3.51935409 |
| 58 | basic amino acid transport (GO:0015802) | 3.49084811 |
| 59 | quaternary ammonium group transport (GO:0015697) | 3.48343295 |
| 60 | uronic acid metabolic process (GO:0006063) | 3.46294665 |
| 61 | glucuronate metabolic process (GO:0019585) | 3.46294665 |
| 62 | protein-lipid complex assembly (GO:0065005) | 3.46235073 |
| 63 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 3.45356285 |
| 64 | glutathione biosynthetic process (GO:0006750) | 3.44431658 |
| 65 | protein hydroxylation (GO:0018126) | 3.43746462 |
| 66 | import into cell (GO:0098657) | 3.42740203 |
| 67 | lung-associated mesenchyme development (GO:0060484) | 3.39955558 |
| 68 | vitamin transmembrane transport (GO:0035461) | 3.39786178 |
| 69 | nucleotide transmembrane transport (GO:1901679) | 3.31934330 |
| 70 | spindle assembly involved in mitosis (GO:0090307) | 3.31190795 |
| 71 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.29410629 |
| 72 | phospholipid homeostasis (GO:0055091) | 3.29059938 |
| 73 | fructose metabolic process (GO:0006000) | 3.29050671 |
| 74 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.28299959 |
| 75 | regulation of prostaglandin secretion (GO:0032306) | 3.26863967 |
| 76 | pentose-phosphate shunt (GO:0006098) | 3.26682642 |
| 77 | regulation of cholesterol esterification (GO:0010872) | 3.24934136 |
| 78 | cholesterol efflux (GO:0033344) | 3.24724829 |
| 79 | AMP metabolic process (GO:0046033) | 3.24234320 |
| 80 | response to hydroperoxide (GO:0033194) | 3.22508832 |
| 81 | positive regulation of prostaglandin secretion (GO:0032308) | 3.22066529 |
| 82 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.21524092 |
| 83 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 3.21033218 |
| 84 | progesterone metabolic process (GO:0042448) | 3.20989221 |
| 85 | amino acid salvage (GO:0043102) | 3.19657718 |
| 86 | L-methionine salvage (GO:0071267) | 3.19657718 |
| 87 | L-methionine biosynthetic process (GO:0071265) | 3.19657718 |
| 88 | peptidyl-proline hydroxylation (GO:0019511) | 3.18607635 |
| 89 | NADH metabolic process (GO:0006734) | 3.16198969 |
| 90 | NADPH regeneration (GO:0006740) | 3.14515557 |
| 91 | heme transport (GO:0015886) | 3.14088854 |
| 92 | regulation of cGMP biosynthetic process (GO:0030826) | 3.09999411 |
| 93 | nephron tubule formation (GO:0072079) | 3.09956962 |
| 94 | dopamine biosynthetic process (GO:0042416) | 3.09945907 |
| 95 | viral entry into host cell (GO:0046718) | 3.09909090 |
| 96 | notochord development (GO:0030903) | 3.09717595 |
| 97 | high-density lipoprotein particle remodeling (GO:0034375) | 3.09380720 |
| 98 | intestinal epithelial cell development (GO:0060576) | 3.09240760 |
| 99 | serine family amino acid metabolic process (GO:0009069) | 3.08728651 |
| 100 | primary alcohol catabolic process (GO:0034310) | 3.07871626 |
| 101 | prostaglandin metabolic process (GO:0006693) | 3.05753614 |
| 102 | prostanoid metabolic process (GO:0006692) | 3.05753614 |
| 103 | glycosylceramide metabolic process (GO:0006677) | 3.05219002 |
| 104 | 4-hydroxyproline metabolic process (GO:0019471) | 3.05106133 |
| 105 | regulation of SMAD protein import into nucleus (GO:0060390) | 3.04762968 |
| 106 | diol metabolic process (GO:0034311) | 3.03949614 |
| 107 | thrombin receptor signaling pathway (GO:0070493) | 3.01940887 |
| 108 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 3.01795504 |
| 109 | creatine metabolic process (GO:0006600) | 3.01139250 |
| 110 | ribosome assembly (GO:0042255) | 3.01067177 |
| 111 | nucleobase biosynthetic process (GO:0046112) | 3.00260640 |
| 112 | labyrinthine layer development (GO:0060711) | 3.00151158 |
| 113 | histone-serine phosphorylation (GO:0035404) | 3.00038939 |
| 114 | carnitine transport (GO:0015879) | 2.99930329 |
| 115 | amino-acid betaine transport (GO:0015838) | 2.99930329 |
| 116 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.99838793 |
| 117 | sphingosine metabolic process (GO:0006670) | 2.98635821 |
| 118 | regulation of early endosome to late endosome transport (GO:2000641) | 2.97128487 |
| 119 | DNA deamination (GO:0045006) | 2.96806815 |
| 120 | oligosaccharide catabolic process (GO:0009313) | 2.96737417 |
| 121 | sphingomyelin metabolic process (GO:0006684) | 2.95227055 |
| 122 | N-acetylneuraminate metabolic process (GO:0006054) | 2.92927783 |
| 123 | positive regulation of respiratory burst (GO:0060267) | 2.92857645 |
| 124 | pseudouridine synthesis (GO:0001522) | 2.92700206 |
| 125 | fibroblast migration (GO:0010761) | 2.92104134 |
| 126 | homocysteine metabolic process (GO:0050667) | 2.92100405 |
| 127 | steroid catabolic process (GO:0006706) | 2.91613840 |
| 128 | nephron epithelium morphogenesis (GO:0072088) | 2.90004715 |
| 129 | nephron tubule morphogenesis (GO:0072078) | 2.90004715 |
| 130 | acylglycerol homeostasis (GO:0055090) | 2.89155978 |
| 131 | triglyceride homeostasis (GO:0070328) | 2.89155978 |
| 132 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.88066519 |
| 133 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.87810846 |
| 134 | glycosphingolipid biosynthetic process (GO:0006688) | 2.87097167 |
| 135 | organic cation transport (GO:0015695) | 2.86976945 |
| 136 | positive regulation of T cell apoptotic process (GO:0070234) | 2.86923873 |
| 137 | pantothenate metabolic process (GO:0015939) | 2.86852199 |
| 138 | positive regulation of epidermis development (GO:0045684) | 2.85373163 |
| 139 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.83864882 |
| 140 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.83143366 |
| 141 | galactose catabolic process (GO:0019388) | 2.80257379 |
| 142 | cell adhesion mediated by integrin (GO:0033627) | 2.80229130 |
| 143 | cofactor transport (GO:0051181) | 2.78412001 |
| 144 | regulation of oxidative phosphorylation (GO:0002082) | 2.78330403 |
| 145 | serine family amino acid catabolic process (GO:0009071) | 2.77354893 |
| 146 | regulation of cellular respiration (GO:0043457) | 2.75048332 |
| 147 | regulation of hippo signaling (GO:0035330) | 2.74909330 |
| 148 | glyoxylate metabolic process (GO:0046487) | 2.74247192 |
| 149 | regulation of apoptotic cell clearance (GO:2000425) | 2.74036827 |
| 150 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 2.73573093 |
| 151 | gland morphogenesis (GO:0022612) | 2.73249662 |
| 152 | lysine metabolic process (GO:0006553) | 2.72250188 |
| 153 | lysine catabolic process (GO:0006554) | 2.72250188 |
| 154 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.71310583 |
| 155 | ADP metabolic process (GO:0046031) | 2.71173784 |
| 156 | low-density lipoprotein particle remodeling (GO:0034374) | 2.69685823 |
| 157 | carnitine transmembrane transport (GO:1902603) | 2.69221485 |
| 158 | DNA damage induced protein phosphorylation (GO:0006975) | 2.69159844 |
| 159 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.67147791 |
| 160 | plasma lipoprotein particle clearance (GO:0034381) | 2.66205291 |
| 161 | reverse cholesterol transport (GO:0043691) | 2.65441646 |
| 162 | carbohydrate derivative transport (GO:1901264) | 2.64055560 |
| 163 | somite rostral/caudal axis specification (GO:0032525) | 2.63743513 |
| 164 | artery smooth muscle contraction (GO:0014824) | 2.62265184 |
| 165 | regulation of metalloenzyme activity (GO:0048552) | 2.60507944 |
| 166 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.60417329 |
| 167 | regulation of bile acid biosynthetic process (GO:0070857) | 2.60199938 |
| 168 | respiratory chain complex IV assembly (GO:0008535) | 2.59639709 |
| 169 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.59034681 |
| 170 | plasma lipoprotein particle organization (GO:0071827) | 2.58401286 |
| 171 | regulation of acrosome reaction (GO:0060046) | 2.56007355 |
| 172 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.55729379 |
| 173 | L-phenylalanine metabolic process (GO:0006558) | 2.54154004 |
| 174 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.54154004 |
| 175 | male meiosis I (GO:0007141) | 2.53637556 |
| 176 | rRNA modification (GO:0000154) | 2.52843841 |
| 177 | C4-dicarboxylate transport (GO:0015740) | 2.51184493 |
| 178 | retinal metabolic process (GO:0042574) | 2.49637448 |
| 179 | C21-steroid hormone metabolic process (GO:0008207) | 2.49410227 |
| 180 | nitric oxide biosynthetic process (GO:0006809) | 2.48304229 |
| 181 | primitive streak formation (GO:0090009) | 2.44023400 |
| 182 | transcription from mitochondrial promoter (GO:0006390) | 2.40925468 |
| 183 | regulation of chemokine secretion (GO:0090196) | 2.40738611 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.26385114 |
| 2 | ZNF274_21170338_ChIP-Seq_K562_Hela | 4.07492520 |
| 3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.72928588 |
| 4 | AR_21909140_ChIP-Seq_LNCAP_Human | 3.57358907 |
| 5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.28883219 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.24645563 |
| 7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.24098366 |
| 8 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.91451974 |
| 9 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.68985834 |
| 10 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.61693404 |
| 11 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.56610636 |
| 12 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.53148846 |
| 13 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.50607062 |
| 14 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 2.48105505 |
| 15 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.31762393 |
| 16 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.30539384 |
| 17 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.24122808 |
| 18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.20316793 |
| 19 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.17330358 |
| 20 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.11244142 |
| 21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.10856309 |
| 22 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 2.07411534 |
| 23 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.06265053 |
| 24 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.05809553 |
| 25 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.02549482 |
| 26 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.01205214 |
| 27 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.00438464 |
| 28 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.98998695 |
| 29 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.97600999 |
| 30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.91917372 |
| 31 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.91878105 |
| 32 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.86638391 |
| 33 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.85596007 |
| 34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.80493510 |
| 35 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.79128454 |
| 36 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.78970484 |
| 37 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.78779694 |
| 38 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.78464896 |
| 39 | VDR_22108803_ChIP-Seq_LS180_Human | 1.77252216 |
| 40 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.76481327 |
| 41 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.76481327 |
| 42 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.74787446 |
| 43 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.73394267 |
| 44 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.72827768 |
| 45 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.70254507 |
| 46 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.67882890 |
| 47 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.67859935 |
| 48 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.67649984 |
| 49 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.67353910 |
| 50 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.67202747 |
| 51 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.67009925 |
| 52 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.66520709 |
| 53 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.66360726 |
| 54 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.65988268 |
| 55 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.65014879 |
| 56 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.62072607 |
| 57 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.60317679 |
| 58 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.60224381 |
| 59 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.59999008 |
| 60 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.56303207 |
| 61 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.56251073 |
| 62 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.55056666 |
| 63 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.53959036 |
| 64 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.52257750 |
| 65 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.51499820 |
| 66 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.48742544 |
| 67 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.48428621 |
| 68 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.48155365 |
| 69 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.47494460 |
| 70 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.47319143 |
| 71 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.47044891 |
| 72 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.46730253 |
| 73 | ATF3_27146783_Chip-Seq_COLON_Human | 1.46043687 |
| 74 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.44873274 |
| 75 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.44682347 |
| 76 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.44602494 |
| 77 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.44105549 |
| 78 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.43790954 |
| 79 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.42176720 |
| 80 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.41327472 |
| 81 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.39663787 |
| 82 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.37827696 |
| 83 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.33476821 |
| 84 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.33098165 |
| 85 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.32950679 |
| 86 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.32488504 |
| 87 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.30491155 |
| 88 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.30401220 |
| 89 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.30311175 |
| 90 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.30007377 |
| 91 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.29096955 |
| 92 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.28453218 |
| 93 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.28345172 |
| 94 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.27278723 |
| 95 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.26896522 |
| 96 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.26792330 |
| 97 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.26502555 |
| 98 | TP53_16413492_ChIP-PET_HCT116_Human | 1.25331300 |
| 99 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.24668996 |
| 100 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.24197139 |
| 101 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.23920242 |
| 102 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.23876730 |
| 103 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.23257840 |
| 104 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.21479490 |
| 105 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.19639419 |
| 106 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.19193860 |
| 107 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.19012994 |
| 108 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.18910342 |
| 109 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.18834724 |
| 110 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.18363218 |
| 111 | P300_19829295_ChIP-Seq_ESCs_Human | 1.18340204 |
| 112 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17775790 |
| 113 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17744733 |
| 114 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.16128007 |
| 115 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.15530549 |
| 116 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.14607458 |
| 117 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.14607458 |
| 118 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.14324968 |
| 119 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.13435809 |
| 120 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.12743820 |
| 121 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.12271382 |
| 122 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.12209903 |
| 123 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.11495179 |
| 124 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.08764386 |
| 125 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.06737326 |
| 126 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.06737326 |
| 127 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.06481870 |
| 128 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06269774 |
| 129 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.05347614 |
| 130 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.05188186 |
| 131 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.03442557 |
| 132 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.03323262 |
| 133 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.03226449 |
| 134 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.02558154 |
| 135 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.02131364 |
| 136 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01980217 |
| 137 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.01481109 |
| 138 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.01112965 |
| 139 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.00668725 |
| 140 | AR_20517297_ChIP-Seq_VCAP_Human | 1.00582420 |
| 141 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.00118084 |
| 142 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.99826704 |
| 143 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.99796372 |
| 144 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.99791561 |
| 145 | NCOR_22424771_ChIP-Seq_293T_Human | 0.99484808 |
| 146 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.99435200 |
| 147 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.99296268 |
| 148 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.99206002 |
| 149 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.99162906 |
| 150 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.99123853 |
| 151 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.99000571 |
| 152 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98752976 |
| 153 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.96555685 |
| 154 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95969081 |
| 155 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95291665 |
| 156 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.94116506 |
| 157 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.93600385 |
| 158 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.92624058 |
| 159 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.92546600 |
| 160 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.92526098 |
| 161 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.92381532 |
| 162 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.92381532 |
| 163 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.92087165 |
| 164 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.90939239 |
| 165 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.89549334 |
| 166 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.88890762 |
| 167 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.88109936 |
| 168 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.87633077 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002138_abnormal_hepatobiliary_system | 6.48856108 |
| 2 | MP0004019_abnormal_vitamin_homeostasis | 5.06402218 |
| 3 | MP0003950_abnormal_plasma_membrane | 3.61561573 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.36917833 |
| 5 | MP0001756_abnormal_urination | 3.16257882 |
| 6 | MP0001765_abnormal_ion_homeostasis | 3.12789117 |
| 7 | MP0009643_abnormal_urine_homeostasis | 3.07405055 |
| 8 | MP0003195_calcinosis | 2.92212598 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.87081326 |
| 10 | MP0005365_abnormal_bile_salt | 2.81603321 |
| 11 | MP0010234_abnormal_vibrissa_follicle | 2.77397432 |
| 12 | MP0005636_abnormal_mineral_homeostasis | 2.74971584 |
| 13 | MP0005332_abnormal_amino_acid | 2.72095798 |
| 14 | MP0001958_emphysema | 2.70061835 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.68613353 |
| 16 | MP0003252_abnormal_bile_duct | 2.61664816 |
| 17 | MP0006054_spinal_hemorrhage | 2.61609535 |
| 18 | MP0002136_abnormal_kidney_physiology | 2.59312338 |
| 19 | MP0005360_urolithiasis | 2.48936449 |
| 20 | MP0009840_abnormal_foam_cell | 2.46650063 |
| 21 | MP0003693_abnormal_embryo_hatching | 2.34889211 |
| 22 | MP0000647_abnormal_sebaceous_gland | 2.34629798 |
| 23 | MP0003890_abnormal_embryonic-extraembry | 2.32433166 |
| 24 | MP0005058_abnormal_lysosome_morphology | 2.26417682 |
| 25 | MP0008872_abnormal_physiological_respon | 2.12767105 |
| 26 | MP0010329_abnormal_lipoprotein_level | 2.01500596 |
| 27 | MP0002876_abnormal_thyroid_physiology | 1.88768350 |
| 28 | MP0001661_extended_life_span | 1.76795790 |
| 29 | MP0005377_hearing/vestibular/ear_phenot | 1.74681436 |
| 30 | MP0003878_abnormal_ear_physiology | 1.74681436 |
| 31 | MP0002736_abnormal_nociception_after | 1.74135964 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.70781596 |
| 33 | MP0003329_amyloid_beta_deposits | 1.68830065 |
| 34 | MP0002928_abnormal_bile_duct | 1.67872178 |
| 35 | MP0005408_hypopigmentation | 1.67348660 |
| 36 | MP0004957_abnormal_blastocyst_morpholog | 1.65052191 |
| 37 | MP0001968_abnormal_touch/_nociception | 1.55699308 |
| 38 | MP0010352_gastrointestinal_tract_polyps | 1.53817761 |
| 39 | MP0000604_amyloidosis | 1.53808154 |
| 40 | MP0004264_abnormal_extraembryonic_tissu | 1.52193872 |
| 41 | MP0001986_abnormal_taste_sensitivity | 1.44613422 |
| 42 | MP0003111_abnormal_nucleus_morphology | 1.43466998 |
| 43 | MP0001727_abnormal_embryo_implantation | 1.43177663 |
| 44 | MP0003718_maternal_effect | 1.41607731 |
| 45 | MP0005395_other_phenotype | 1.41438811 |
| 46 | MP0002168_other_aberrant_phenotype | 1.41123253 |
| 47 | MP0003566_abnormal_cell_adhesion | 1.40534494 |
| 48 | MP0002796_impaired_skin_barrier | 1.36442351 |
| 49 | MP0003045_fibrosis | 1.36237843 |
| 50 | MP0000681_abnormal_thyroid_gland | 1.31321358 |
| 51 | MP0002254_reproductive_system_inflammat | 1.30990339 |
| 52 | MP0004133_heterotaxia | 1.26591791 |
| 53 | MP0004043_abnormal_pH_regulation | 1.25361398 |
| 54 | MP0004782_abnormal_surfactant_physiolog | 1.24562586 |
| 55 | MP0005084_abnormal_gallbladder_morpholo | 1.22768444 |
| 56 | MP0010678_abnormal_skin_adnexa | 1.22404837 |
| 57 | MP0003315_abnormal_perineum_morphology | 1.22141604 |
| 58 | MP0000427_abnormal_hair_cycle | 1.20580048 |
| 59 | MP0003567_abnormal_fetal_cardiomyocyte | 1.19371847 |
| 60 | MP0000013_abnormal_adipose_tissue | 1.15047916 |
| 61 | MP0006276_abnormal_autonomic_nervous | 1.14362486 |
| 62 | MP0005551_abnormal_eye_electrophysiolog | 1.11658172 |
| 63 | MP0005410_abnormal_fertilization | 1.10061386 |
| 64 | MP0006035_abnormal_mitochondrial_morpho | 1.08026717 |
| 65 | MP0003186_abnormal_redox_activity | 1.05852336 |
| 66 | MP0003806_abnormal_nucleotide_metabolis | 1.05628427 |
| 67 | MP0008438_abnormal_cutaneous_collagen | 1.05185073 |
| 68 | MP0002135_abnormal_kidney_morphology | 1.04944450 |
| 69 | MP0004084_abnormal_cardiac_muscle | 1.02256707 |
| 70 | MP0001348_abnormal_lacrimal_gland | 1.02011565 |
| 71 | MP0006082_CNS_inflammation | 1.01028643 |
| 72 | MP0001764_abnormal_homeostasis | 1.00466219 |
| 73 | MP0004883_abnormal_blood_vessel | 0.98492766 |
| 74 | MP0003183_abnormal_peptide_metabolism | 0.96077565 |
| 75 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.95239867 |
| 76 | MP0000358_abnormal_cell_content/ | 0.92665719 |
| 77 | MP0005085_abnormal_gallbladder_physiolo | 0.92393247 |
| 78 | MP0004272_abnormal_basement_membrane | 0.91617460 |
| 79 | MP0001730_embryonic_growth_arrest | 0.90476180 |
| 80 | MP0008260_abnormal_autophagy | 0.90135508 |
| 81 | MP0005646_abnormal_pituitary_gland | 0.87698917 |
| 82 | MP0003646_muscle_fatigue | 0.86288443 |
| 83 | MP0000639_abnormal_adrenal_gland | 0.85970869 |
| 84 | MP0001666_abnormal_nutrient_absorption | 0.85651793 |
| 85 | MP0005023_abnormal_wound_healing | 0.85216325 |
| 86 | MP0005670_abnormal_white_adipose | 0.85118945 |
| 87 | MP0005379_endocrine/exocrine_gland_phen | 0.84632859 |
| 88 | MP0008961_abnormal_basal_metabolism | 0.83934665 |
| 89 | MP0008775_abnormal_heart_ventricle | 0.82443356 |
| 90 | MP0000383_abnormal_hair_follicle | 0.81333048 |
| 91 | MP0003091_abnormal_cell_migration | 0.81251612 |
| 92 | MP0008932_abnormal_embryonic_tissue | 0.78241957 |
| 93 | MP0005220_abnormal_exocrine_pancreas | 0.77596221 |
| 94 | MP0005409_darkened_coat_color | 0.77229064 |
| 95 | MP0005195_abnormal_posterior_eye | 0.76522406 |
| 96 | MP0003943_abnormal_hepatobiliary_system | 0.76326472 |
| 97 | MP0005165_increased_susceptibility_to | 0.76059657 |
| 98 | MP0006292_abnormal_olfactory_placode | 0.74216896 |
| 99 | MP0002233_abnormal_nose_morphology | 0.73967497 |
| 100 | MP0005389_reproductive_system_phenotype | 0.73946678 |
| 101 | MP0001881_abnormal_mammary_gland | 0.73302750 |
| 102 | MP0001286_abnormal_eye_development | 0.73263727 |
| 103 | MP0008789_abnormal_olfactory_epithelium | 0.72848204 |
| 104 | MP0002102_abnormal_ear_morphology | 0.72560090 |
| 105 | MP0000627_abnormal_mammary_gland | 0.72165491 |
| 106 | MP0003879_abnormal_hair_cell | 0.71698410 |
| 107 | MP0000598_abnormal_liver_morphology | 0.69691998 |
| 108 | MP0001177_atelectasis | 0.69570089 |
| 109 | MP0009278_abnormal_bone_marrow | 0.68801619 |
| 110 | MP0004484_altered_response_of | 0.67907396 |
| 111 | MP0005501_abnormal_skin_physiology | 0.67279779 |
| 112 | MP0000609_abnormal_liver_physiology | 0.67169303 |
| 113 | MP0008004_abnormal_stomach_pH | 0.66775917 |
| 114 | MP0002909_abnormal_adrenal_gland | 0.66375953 |
| 115 | MP0001485_abnormal_pinna_reflex | 0.64862721 |
| 116 | MP0000377_abnormal_hair_follicle | 0.63055698 |
| 117 | MP0001915_intracranial_hemorrhage | 0.62873375 |
| 118 | MP0003077_abnormal_cell_cycle | 0.62870984 |
| 119 | MP0001919_abnormal_reproductive_system | 0.62318288 |
| 120 | MP0002086_abnormal_extraembryonic_tissu | 0.62242710 |
| 121 | MP0003638_abnormal_response/metabolism_ | 0.62179000 |
| 122 | MP0002089_abnormal_postnatal_growth/wei | 0.61741508 |
| 123 | MP0003936_abnormal_reproductive_system | 0.60551288 |
| 124 | MP0000230_abnormal_systemic_arterial | 0.60014053 |
| 125 | MP0005164_abnormal_response_to | 0.59995731 |
| 126 | MP0001929_abnormal_gametogenesis | 0.59883432 |
| 127 | MP0006036_abnormal_mitochondrial_physio | 0.58907661 |
| 128 | MP0001664_abnormal_digestion | 0.58494099 |
| 129 | MP0002098_abnormal_vibrissa_morphology | 0.58493121 |
| 130 | MP0001542_abnormal_bone_strength | 0.58072074 |
| 131 | MP0002269_muscular_atrophy | 0.57705585 |
| 132 | MP0000343_altered_response_to | 0.57259129 |
| 133 | MP0002163_abnormal_gland_morphology | 0.56897331 |
| 134 | MP0003938_abnormal_ear_development | 0.56665089 |
| 135 | MP0002210_abnormal_sex_determination | 0.56004786 |
| 136 | MP0005166_decreased_susceptibility_to | 0.54623057 |
| 137 | MP0001216_abnormal_epidermal_layer | 0.54609125 |
| 138 | MP0004215_abnormal_myocardial_fiber | 0.53984389 |
| 139 | MP0001293_anophthalmia | 0.53959293 |
| 140 | MP0009333_abnormal_splenocyte_physiolog | 0.53923190 |
| 141 | MP0001944_abnormal_pancreas_morphology | 0.53862881 |
| 142 | MP0001672_abnormal_embryogenesis/_devel | 0.53589359 |
| 143 | MP0005380_embryogenesis_phenotype | 0.53589359 |
| 144 | MP0003632_abnormal_nervous_system | 0.53390221 |
| 145 | MP0002088_abnormal_embryonic_growth/wei | 0.53354010 |
| 146 | MP0002118_abnormal_lipid_homeostasis | 0.53348057 |
| 147 | MP0001697_abnormal_embryo_size | 0.53045285 |
| 148 | MP0005319_abnormal_enzyme/_coenzyme | 0.52649079 |
| 149 | MP0003984_embryonic_growth_retardation | 0.52352800 |
| 150 | MP0005451_abnormal_body_composition | 0.51351559 |
| 151 | MP0005197_abnormal_uvea_morphology | 0.51298688 |
| 152 | MP0008877_abnormal_DNA_methylation | 0.50958055 |
| 153 | MP0002697_abnormal_eye_size | 0.50405606 |
| 154 | MP0005394_taste/olfaction_phenotype | 0.49410871 |
| 155 | MP0005499_abnormal_olfactory_system | 0.49410871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Gout (HP:0001997) | 7.16905752 |
| 2 | Conjugated hyperbilirubinemia (HP:0002908) | 5.40225238 |
| 3 | Arterial tortuosity (HP:0005116) | 4.41336771 |
| 4 | Increased purine levels (HP:0004368) | 4.26647638 |
| 5 | Hyperuricemia (HP:0002149) | 4.26647638 |
| 6 | Spondylolisthesis (HP:0003302) | 4.14272267 |
| 7 | Amelogenesis imperfecta (HP:0000705) | 3.99313223 |
| 8 | Polyuria (HP:0000103) | 3.95332515 |
| 9 | Malnutrition (HP:0004395) | 3.88579184 |
| 10 | Vascular tortuosity (HP:0004948) | 3.86995229 |
| 11 | Facial shape deformation (HP:0011334) | 3.83979564 |
| 12 | Potter facies (HP:0002009) | 3.83979564 |
| 13 | Proximal tubulopathy (HP:0000114) | 3.78593930 |
| 14 | Abnormality of the nasal septum (HP:0000419) | 3.64413547 |
| 15 | Aortic dissection (HP:0002647) | 3.63935737 |
| 16 | Bilateral microphthalmos (HP:0007633) | 3.62095443 |
| 17 | Metabolic alkalosis (HP:0200114) | 3.62043897 |
| 18 | Abnormal urine output (HP:0012590) | 3.61851162 |
| 19 | Megaloblastic anemia (HP:0001889) | 3.45218066 |
| 20 | Abnormality of renal excretion (HP:0011036) | 3.41744375 |
| 21 | Abnormality of purine metabolism (HP:0004352) | 3.36936790 |
| 22 | Hypoplasia of the fovea (HP:0007750) | 3.35508161 |
| 23 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.35508161 |
| 24 | Elfin facies (HP:0004428) | 3.23772326 |
| 25 | Vacuolated lymphocytes (HP:0001922) | 3.23567273 |
| 26 | Aplasia/hypoplasia of the uterus (HP:0008684) | 3.19353663 |
| 27 | Glucose intolerance (HP:0000833) | 3.18504213 |
| 28 | Spontaneous abortion (HP:0005268) | 3.15971204 |
| 29 | Premature rupture of membranes (HP:0001788) | 3.14772638 |
| 30 | Esophageal varix (HP:0002040) | 3.14305768 |
| 31 | Glycosuria (HP:0003076) | 3.09006592 |
| 32 | Abnormality of urine glucose concentration (HP:0011016) | 3.09006592 |
| 33 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.07865746 |
| 34 | Fused cervical vertebrae (HP:0002949) | 3.06342355 |
| 35 | Tubulointerstitial fibrosis (HP:0005576) | 3.00804600 |
| 36 | Abnormal drinking behavior (HP:0030082) | 2.99487286 |
| 37 | Polydipsia (HP:0001959) | 2.99487286 |
| 38 | Abnormal pancreas size (HP:0012094) | 2.99329490 |
| 39 | Cerebellar dysplasia (HP:0007033) | 2.92957764 |
| 40 | Increased circulating renin level (HP:0000848) | 2.91355303 |
| 41 | Hypokalemic alkalosis (HP:0001949) | 2.90785439 |
| 42 | Muscle fiber splitting (HP:0003555) | 2.88406828 |
| 43 | Renal tubular dysfunction (HP:0000124) | 2.85960048 |
| 44 | Stomach cancer (HP:0012126) | 2.84380854 |
| 45 | Hypobetalipoproteinemia (HP:0003563) | 2.82666278 |
| 46 | Carpal bone hypoplasia (HP:0001498) | 2.82590117 |
| 47 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.82412631 |
| 48 | Ileus (HP:0002595) | 2.81868069 |
| 49 | Abnormality of proline metabolism (HP:0010907) | 2.80548515 |
| 50 | Hydroxyprolinuria (HP:0003080) | 2.80548515 |
| 51 | Generalized aminoaciduria (HP:0002909) | 2.76660729 |
| 52 | Neonatal death (HP:0003811) | 2.75160268 |
| 53 | Abnormality of renin-angiotensin system (HP:0000847) | 2.74751229 |
| 54 | Abnormality of the common coagulation pathway (HP:0010990) | 2.74119619 |
| 55 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.73977614 |
| 56 | Abnormality of alanine metabolism (HP:0010916) | 2.73977614 |
| 57 | Hyperalaninemia (HP:0003348) | 2.73977614 |
| 58 | Neoplasm of the adrenal cortex (HP:0100641) | 2.72800707 |
| 59 | Hyperactive renin-angiotensin system (HP:0000841) | 2.71334963 |
| 60 | Confusion (HP:0001289) | 2.67957965 |
| 61 | Abnormality of dental color (HP:0011073) | 2.65492335 |
| 62 | Dehydration (HP:0001944) | 2.64122077 |
| 63 | Bicornuate uterus (HP:0000813) | 2.63818191 |
| 64 | Chorioretinal atrophy (HP:0000533) | 2.63502832 |
| 65 | Abnormality of glycolipid metabolism (HP:0010969) | 2.61650035 |
| 66 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.61650035 |
| 67 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.61650035 |
| 68 | Hypercalciuria (HP:0002150) | 2.61455103 |
| 69 | Increased serum pyruvate (HP:0003542) | 2.59333286 |
| 70 | Decreased circulating renin level (HP:0003351) | 2.58207648 |
| 71 | Late onset (HP:0003584) | 2.55703449 |
| 72 | Long clavicles (HP:0000890) | 2.55602834 |
| 73 | Increased cerebral lipofuscin (HP:0011813) | 2.55441131 |
| 74 | Abnormality of the fovea (HP:0000493) | 2.54548930 |
| 75 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.53086615 |
| 76 | Osteolytic defects of the hand bones (HP:0009699) | 2.53086615 |
| 77 | Hypothermia (HP:0002045) | 2.51506703 |
| 78 | Hyperglycinuria (HP:0003108) | 2.51252495 |
| 79 | Delayed epiphyseal ossification (HP:0002663) | 2.50549688 |
| 80 | Alkalosis (HP:0001948) | 2.49753986 |
| 81 | Abnormality of chloride homeostasis (HP:0011422) | 2.49700718 |
| 82 | Retinal atrophy (HP:0001105) | 2.47482105 |
| 83 | Hypomagnesemia (HP:0002917) | 2.46527401 |
| 84 | Ankle contracture (HP:0006466) | 2.43199685 |
| 85 | Rough bone trabeculation (HP:0100670) | 2.42541675 |
| 86 | Abnormal trabecular bone morphology (HP:0100671) | 2.40815004 |
| 87 | Nephrocalcinosis (HP:0000121) | 2.40372105 |
| 88 | Abnormality of the renal cortex (HP:0011035) | 2.39300116 |
| 89 | Hyperglycinemia (HP:0002154) | 2.38319792 |
| 90 | Renal tubular acidosis (HP:0001947) | 2.38185223 |
| 91 | Nausea (HP:0002018) | 2.36371125 |
| 92 | Hypoplasia of the uterus (HP:0000013) | 2.35032628 |
| 93 | Focal segmental glomerulosclerosis (HP:0000097) | 2.33984892 |
| 94 | Abnormality of nucleobase metabolism (HP:0010932) | 2.33831691 |
| 95 | Hypophosphatemic rickets (HP:0004912) | 2.32291882 |
| 96 | Type II lissencephaly (HP:0007260) | 2.24510444 |
| 97 | Osteomalacia (HP:0002749) | 2.23975846 |
| 98 | Renal cortical cysts (HP:0000803) | 2.23971540 |
| 99 | Abnormality of the aortic arch (HP:0012303) | 2.23681555 |
| 100 | Aortic valve stenosis (HP:0001650) | 2.21426379 |
| 101 | Tubular atrophy (HP:0000092) | 2.21031837 |
| 102 | Sensorimotor neuropathy (HP:0007141) | 2.20104959 |
| 103 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.18110662 |
| 104 | Abnormality of magnesium homeostasis (HP:0004921) | 2.15823729 |
| 105 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.15799442 |
| 106 | Abnormality of glycine metabolism (HP:0010895) | 2.15799442 |
| 107 | Abnormality of glycolysis (HP:0004366) | 2.12539399 |
| 108 | Nephrolithiasis (HP:0000787) | 2.12235433 |
| 109 | Abolished electroretinogram (ERG) (HP:0000550) | 2.10640412 |
| 110 | Hypokalemia (HP:0002900) | 2.10509066 |
| 111 | Thyroid-stimulating hormone excess (HP:0002925) | 2.10339434 |
| 112 | Prolonged neonatal jaundice (HP:0006579) | 2.10078805 |
| 113 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.09249972 |
| 114 | Lethargy (HP:0001254) | 2.09010902 |
| 115 | Tetany (HP:0001281) | 2.08588066 |
| 116 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.08098625 |
| 117 | Unilateral renal agenesis (HP:0000122) | 2.07434997 |
| 118 | Broad alveolar ridges (HP:0000187) | 2.06946466 |
| 119 | Shawl scrotum (HP:0000049) | 2.06934205 |
| 120 | Thin bony cortex (HP:0002753) | 2.06576504 |
| 121 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.06394883 |
| 122 | Abnormality of macular pigmentation (HP:0008002) | 2.05886426 |
| 123 | Cone-rod dystrophy (HP:0000548) | 2.03640471 |
| 124 | Autoamputation (HP:0001218) | 2.02515500 |
| 125 | Myopathic facies (HP:0002058) | 1.99774451 |
| 126 | Gastrointestinal dysmotility (HP:0002579) | 1.99479906 |
| 127 | Methylmalonic aciduria (HP:0012120) | 1.98747763 |
| 128 | Renal salt wasting (HP:0000127) | 1.98376517 |
| 129 | Increased CSF lactate (HP:0002490) | 1.98354372 |
| 130 | Abnormality of macrophages (HP:0004311) | 1.98289169 |
| 131 | Breast hypoplasia (HP:0003187) | 1.97148536 |
| 132 | Hyperammonemia (HP:0001987) | 1.96984062 |
| 133 | Bicuspid aortic valve (HP:0001647) | 1.94945625 |
| 134 | Aortic aneurysm (HP:0004942) | 1.94834153 |
| 135 | Dicarboxylic aciduria (HP:0003215) | 1.94390586 |
| 136 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.94390586 |
| 137 | Cervical subluxation (HP:0003308) | 1.93693975 |
| 138 | Pancreatic cysts (HP:0001737) | 1.93678303 |
| 139 | Increased serum ferritin (HP:0003281) | 1.92929210 |
| 140 | Abnormality of serum amino acid levels (HP:0003112) | 1.92626672 |
| 141 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.92146834 |
| 142 | Glomerulosclerosis (HP:0000096) | 1.92142295 |
| 143 | Abnormal glucose tolerance (HP:0001952) | 1.90869743 |
| 144 | Vascular calcification (HP:0004934) | 1.90276736 |
| 145 | Vomiting (HP:0002013) | 1.89798754 |
| 146 | Mucopolysacchariduria (HP:0008155) | 1.89711923 |
| 147 | Hypolipoproteinemia (HP:0010981) | 1.89622967 |
| 148 | Short tibia (HP:0005736) | 1.83851010 |
| 149 | Vitreoretinal degeneration (HP:0000655) | 1.81107525 |
| 150 | Pendular nystagmus (HP:0012043) | 1.80430823 |
| 151 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.79786108 |
| 152 | Azoospermia (HP:0000027) | 1.78712620 |
| 153 | Increased serum lactate (HP:0002151) | 1.78327288 |
| 154 | Stenosis of the external auditory canal (HP:0000402) | 1.78041833 |
| 155 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.77809810 |
| 156 | Mitochondrial inheritance (HP:0001427) | 1.67776666 |
| 157 | Paralysis (HP:0003470) | 1.67300669 |
| 158 | Stage 5 chronic kidney disease (HP:0003774) | 1.64157635 |
| 159 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.63938458 |
| 160 | Renal hypoplasia (HP:0000089) | 1.63000149 |
| 161 | Acute necrotizing encephalopathy (HP:0006965) | 1.62975983 |
| 162 | Patent foramen ovale (HP:0001655) | 1.60838727 |
| 163 | Increased hepatocellular lipid droplets (HP:0006565) | 1.60344974 |
| 164 | Cerebral palsy (HP:0100021) | 1.59869266 |
| 165 | Hyperphosphaturia (HP:0003109) | 1.58747173 |
| 166 | Abnormality of the renal medulla (HP:0100957) | 1.57895498 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 6.18417075 |
| 2 | ZAK | 4.94746523 |
| 3 | BUB1 | 3.50902344 |
| 4 | WEE1 | 3.47282192 |
| 5 | PBK | 3.41889429 |
| 6 | TTK | 3.08200661 |
| 7 | WNK4 | 2.66010366 |
| 8 | PNCK | 2.63558045 |
| 9 | MST1R | 2.36505169 |
| 10 | FRK | 2.30303864 |
| 11 | NEK1 | 2.09577872 |
| 12 | MAP4K2 | 2.09122786 |
| 13 | BMPR1B | 1.99578129 |
| 14 | MST4 | 1.97313933 |
| 15 | NME1 | 1.84007787 |
| 16 | EIF2AK1 | 1.83027375 |
| 17 | MYLK | 1.81312169 |
| 18 | LRRK2 | 1.74075093 |
| 19 | NUAK1 | 1.69698597 |
| 20 | ADRBK2 | 1.67827163 |
| 21 | MAP2K7 | 1.67713263 |
| 22 | STK38L | 1.60126915 |
| 23 | PLK3 | 1.59071357 |
| 24 | AKT3 | 1.58511120 |
| 25 | SGK3 | 1.54155769 |
| 26 | TGFBR2 | 1.54043140 |
| 27 | OXSR1 | 1.51764512 |
| 28 | BRSK2 | 1.49912024 |
| 29 | PRKCI | 1.48526027 |
| 30 | PINK1 | 1.46604314 |
| 31 | RPS6KB2 | 1.46471001 |
| 32 | PDK2 | 1.43056025 |
| 33 | MAP3K3 | 1.41672678 |
| 34 | NEK9 | 1.40028654 |
| 35 | TLK1 | 1.38613929 |
| 36 | ERBB4 | 1.38492283 |
| 37 | MAP3K4 | 1.30235163 |
| 38 | TNIK | 1.27792239 |
| 39 | CASK | 1.25561133 |
| 40 | STK38 | 1.20781818 |
| 41 | PAK4 | 1.20011958 |
| 42 | PDK4 | 1.19867477 |
| 43 | PDK3 | 1.19867477 |
| 44 | GRK1 | 1.16527356 |
| 45 | STK39 | 1.16128351 |
| 46 | NEK2 | 1.15288682 |
| 47 | CDK8 | 1.13386740 |
| 48 | TTN | 1.12702340 |
| 49 | BCR | 1.12553195 |
| 50 | EPHB1 | 1.11659317 |
| 51 | FGFR1 | 1.11480615 |
| 52 | WNK3 | 1.07662804 |
| 53 | BCKDK | 1.07504757 |
| 54 | STK10 | 1.07254288 |
| 55 | PRKCE | 1.07041729 |
| 56 | STK3 | 1.06816374 |
| 57 | PIK3CA | 1.04682634 |
| 58 | ABL2 | 1.01333954 |
| 59 | EIF2AK3 | 0.98902872 |
| 60 | FER | 0.98724628 |
| 61 | ERN1 | 0.98128195 |
| 62 | ACVR1B | 0.98058182 |
| 63 | PLK2 | 0.94638369 |
| 64 | DAPK2 | 0.94533186 |
| 65 | MET | 0.93809283 |
| 66 | LMTK2 | 0.93166964 |
| 67 | NME2 | 0.93166372 |
| 68 | TAOK3 | 0.92923153 |
| 69 | SCYL2 | 0.90443494 |
| 70 | IRAK3 | 0.85565059 |
| 71 | FGFR4 | 0.84962626 |
| 72 | MAP3K8 | 0.84853701 |
| 73 | PAK1 | 0.84627240 |
| 74 | BMX | 0.83035291 |
| 75 | TSSK6 | 0.83010961 |
| 76 | ARAF | 0.80648257 |
| 77 | EPHA3 | 0.80045434 |
| 78 | STK16 | 0.76933700 |
| 79 | INSRR | 0.76712532 |
| 80 | TRIB3 | 0.73693328 |
| 81 | PRKCZ | 0.72317802 |
| 82 | LATS2 | 0.72087847 |
| 83 | TXK | 0.71564704 |
| 84 | ALK | 0.70281963 |
| 85 | PTK2 | 0.69562911 |
| 86 | CSNK1A1L | 0.68678200 |
| 87 | AURKA | 0.67934244 |
| 88 | FGFR2 | 0.67756264 |
| 89 | CHEK2 | 0.66029669 |
| 90 | MAPK11 | 0.64969478 |
| 91 | FLT3 | 0.63653029 |
| 92 | PHKG1 | 0.63518969 |
| 93 | PHKG2 | 0.63518969 |
| 94 | AURKB | 0.62860511 |
| 95 | PLK1 | 0.61638525 |
| 96 | MAP3K12 | 0.61298068 |
| 97 | KDR | 0.59718629 |
| 98 | BRSK1 | 0.59513836 |
| 99 | FGFR3 | 0.56244586 |
| 100 | PKN1 | 0.55557036 |
| 101 | PLK4 | 0.54356976 |
| 102 | LATS1 | 0.53955832 |
| 103 | PRKCQ | 0.53692015 |
| 104 | TESK1 | 0.51774702 |
| 105 | DAPK3 | 0.51075180 |
| 106 | SGK494 | 0.49985081 |
| 107 | SGK223 | 0.49985081 |
| 108 | MAP2K2 | 0.48264224 |
| 109 | RPS6KA4 | 0.48257406 |
| 110 | GSK3A | 0.48207021 |
| 111 | PRKG2 | 0.48049751 |
| 112 | BRAF | 0.46065127 |
| 113 | SRPK1 | 0.45443578 |
| 114 | TRIM28 | 0.44636532 |
| 115 | ERBB2 | 0.44229962 |
| 116 | CAMKK2 | 0.43842033 |
| 117 | PDPK1 | 0.43622718 |
| 118 | PRKCD | 0.43096653 |
| 119 | ADRBK1 | 0.42952344 |
| 120 | CSNK1G1 | 0.42543958 |
| 121 | TAOK1 | 0.41266411 |
| 122 | NTRK3 | 0.40339523 |
| 123 | PTK6 | 0.40169128 |
| 124 | DAPK1 | 0.39344747 |
| 125 | CSNK1E | 0.39125324 |
| 126 | PRKAA1 | 0.38669635 |
| 127 | CDK9 | 0.38547981 |
| 128 | EPHB2 | 0.38501649 |
| 129 | MATK | 0.37821282 |
| 130 | IGF1R | 0.36888946 |
| 131 | PRKCA | 0.36844750 |
| 132 | AKT2 | 0.36695525 |
| 133 | CSNK1A1 | 0.36364904 |
| 134 | MAP3K7 | 0.36340998 |
| 135 | INSR | 0.36124119 |
| 136 | CDK3 | 0.35989296 |
| 137 | CAMK2G | 0.35162932 |
| 138 | CSNK2A1 | 0.34882120 |
| 139 | PRKAA2 | 0.34484743 |
| 140 | STK11 | 0.33174440 |
| 141 | STK4 | 0.32781991 |
| 142 | GRK6 | 0.32663301 |
| 143 | MAP3K9 | 0.32618125 |
| 144 | PAK3 | 0.31514320 |
| 145 | PIK3CG | 0.30859638 |
| 146 | MTOR | 0.30653002 |
| 147 | MAP2K6 | 0.30249743 |
| 148 | CSNK1G3 | 0.29957338 |
| 149 | CAMK2A | 0.29456253 |
| 150 | MAPKAPK2 | 0.28992785 |
| 151 | DMPK | 0.28605467 |
| 152 | PRKCG | 0.27239621 |
| 153 | PRKACB | 0.27082783 |
| 154 | TYK2 | 0.26983127 |
| 155 | MELK | 0.26177147 |
| 156 | PRKACA | 0.25781041 |
| 157 | ILK | 0.24802276 |
| 158 | TESK2 | 0.24738012 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.50882355 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.19320556 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.94443407 |
| 4 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.81795584 |
| 5 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.75717287 |
| 6 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.71585538 |
| 7 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.58736102 |
| 8 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.47461550 |
| 9 | Glutathione metabolism_Homo sapiens_hsa00480 | 2.44046997 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.35880393 |
| 11 | Mineral absorption_Homo sapiens_hsa04978 | 2.34912593 |
| 12 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.27940596 |
| 13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.23382532 |
| 14 | Lysosome_Homo sapiens_hsa04142 | 2.19352455 |
| 15 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.15851913 |
| 16 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.15256456 |
| 17 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.13039821 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.07119722 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.05519011 |
| 20 | Galactose metabolism_Homo sapiens_hsa00052 | 2.05230373 |
| 21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.03948047 |
| 22 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.97290730 |
| 23 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.85821105 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.84392833 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.82982701 |
| 26 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.80223812 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.68061540 |
| 28 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.66478892 |
| 29 | Carbon metabolism_Homo sapiens_hsa01200 | 1.60628012 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.59154835 |
| 31 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.52389679 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.50154177 |
| 33 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.49668246 |
| 34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.47061306 |
| 35 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.38660343 |
| 36 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.38460227 |
| 37 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.37915639 |
| 38 | Phototransduction_Homo sapiens_hsa04744 | 1.37477100 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.36391901 |
| 40 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.36261088 |
| 41 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.34942622 |
| 42 | Basal transcription factors_Homo sapiens_hsa03022 | 1.31832486 |
| 43 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.31802763 |
| 44 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.28655309 |
| 45 | RNA polymerase_Homo sapiens_hsa03020 | 1.23999027 |
| 46 | Protein export_Homo sapiens_hsa03060 | 1.20533253 |
| 47 | Bile secretion_Homo sapiens_hsa04976 | 1.16354221 |
| 48 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.16001167 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.14011447 |
| 50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.12612276 |
| 51 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.11339749 |
| 52 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.09679442 |
| 53 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.07488683 |
| 54 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.05859919 |
| 55 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.05326832 |
| 56 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.02251239 |
| 57 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.01197567 |
| 58 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.00041984 |
| 59 | Peroxisome_Homo sapiens_hsa04146 | 0.99183602 |
| 60 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.99123666 |
| 61 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.98696591 |
| 62 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.98262201 |
| 63 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.98043129 |
| 64 | Tight junction_Homo sapiens_hsa04530 | 0.98042783 |
| 65 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.96824444 |
| 66 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.96503535 |
| 67 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.95432558 |
| 68 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.94716195 |
| 69 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.94476961 |
| 70 | RNA transport_Homo sapiens_hsa03013 | 0.94106252 |
| 71 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.93702975 |
| 72 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.93390962 |
| 73 | Cell cycle_Homo sapiens_hsa04110 | 0.91888193 |
| 74 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.89299389 |
| 75 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.87976133 |
| 76 | ABC transporters_Homo sapiens_hsa02010 | 0.86634171 |
| 77 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.84668287 |
| 78 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.84236464 |
| 79 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.84230048 |
| 80 | Ribosome_Homo sapiens_hsa03010 | 0.81856842 |
| 81 | Homologous recombination_Homo sapiens_hsa03440 | 0.81500551 |
| 82 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.81422400 |
| 83 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.80673319 |
| 84 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.80361920 |
| 85 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.79511490 |
| 86 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.79158009 |
| 87 | Parkinsons disease_Homo sapiens_hsa05012 | 0.75902671 |
| 88 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74914713 |
| 89 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.73500350 |
| 90 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.73033337 |
| 91 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.72127565 |
| 92 | RNA degradation_Homo sapiens_hsa03018 | 0.70718209 |
| 93 | Endocytosis_Homo sapiens_hsa04144 | 0.67122156 |
| 94 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.66622639 |
| 95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.65246460 |
| 96 | Huntingtons disease_Homo sapiens_hsa05016 | 0.64180407 |
| 97 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.64167969 |
| 98 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60376804 |
| 99 | Histidine metabolism_Homo sapiens_hsa00340 | 0.60335272 |
| 100 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.59352835 |
| 101 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57961546 |
| 102 | Retinol metabolism_Homo sapiens_hsa00830 | 0.57714050 |
| 103 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.56389408 |
| 104 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.54552703 |
| 105 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.52494340 |
| 106 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.51102933 |
| 107 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.50955125 |
| 108 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.49711179 |
| 109 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49570483 |
| 110 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.49471554 |
| 111 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.49390083 |
| 112 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.49205085 |
| 113 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.47772431 |
| 114 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47437260 |
| 115 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.45188028 |
| 116 | Focal adhesion_Homo sapiens_hsa04510 | 0.43988516 |
| 117 | Adherens junction_Homo sapiens_hsa04520 | 0.43591357 |
| 118 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42373744 |
| 119 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.41271454 |
| 120 | Purine metabolism_Homo sapiens_hsa00230 | 0.41012770 |
| 121 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.40758906 |
| 122 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.40600941 |
| 123 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.39961947 |
| 124 | Base excision repair_Homo sapiens_hsa03410 | 0.39771419 |
| 125 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.38575780 |
| 126 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37638525 |
| 127 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37626239 |
| 128 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.37472843 |
| 129 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.37019115 |
| 130 | Tuberculosis_Homo sapiens_hsa05152 | 0.34676927 |
| 131 | DNA replication_Homo sapiens_hsa03030 | 0.33884262 |
| 132 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.33785511 |
| 133 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.33676485 |
| 134 | Phagosome_Homo sapiens_hsa04145 | 0.33599681 |
| 135 | Alzheimers disease_Homo sapiens_hsa05010 | 0.31900754 |
| 136 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.31871226 |
| 137 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.31296968 |
| 138 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.31021497 |
| 139 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30864899 |
| 140 | Shigellosis_Homo sapiens_hsa05131 | 0.30644370 |

